417 related articles for article (PubMed ID: 16476537)
21. Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma--results from the ALA-ACRC low-dose theophylline trial.
Eden E; Holbrook JT; Brantly ML; Turino GM; Wise RA
J Asthma; 2007 Oct; 44(8):605-8. PubMed ID: 17943569
[TBL] [Abstract][Full Text] [Related]
22. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
[TBL] [Abstract][Full Text] [Related]
23. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.
Demeo DL; Sandhaus RA; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard S; Burchard E; Stocks JM; Stoller JK; Strange C; Turino GM; Campbell EJ; Silverman EK
Thorax; 2007 Sep; 62(9):806-13. PubMed ID: 17389752
[TBL] [Abstract][Full Text] [Related]
24. Aspects of treatment in alpha 1-antitrypsin deficiency: insights derived from a Swedish PiZZ series.
Eriksson S; Wu MC
Eur Respir J Suppl; 1990 Mar; 9():39s-43s. PubMed ID: 2340050
[TBL] [Abstract][Full Text] [Related]
25. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
[TBL] [Abstract][Full Text] [Related]
26. Alpha-1-antitrypsin associated panniculitis: the MS variant.
Geraminejad P; DeBloom JR; Walling HW; Sontheimer RD; VanBeek M
J Am Acad Dermatol; 2004 Oct; 51(4):645-55. PubMed ID: 15389208
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic differences in alpha 1 antitrypsin-deficient sibling pairs may relate to genetic variation.
Wood AM; Needham M; Simmonds MJ; Newby PR; Gough SC; Stockley RA
COPD; 2008 Dec; 5(6):353-9. PubMed ID: 19353349
[TBL] [Abstract][Full Text] [Related]
29. Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse?
Schmechel DE
Neurotoxicology; 2007 Sep; 28(5):899-914. PubMed ID: 17659342
[TBL] [Abstract][Full Text] [Related]
30. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study.
Lee JH; Haselkorn T; Borish L; Rasouliyan L; Chipps BE; Wenzel SE
Chest; 2007 Dec; 132(6):1882-9. PubMed ID: 18079222
[TBL] [Abstract][Full Text] [Related]
31. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
Bernspång E; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
[TBL] [Abstract][Full Text] [Related]
32. [Alpha 1-antitrypsin deficiency: the Brescia clinical study].
Pini L; Corda L; Malerba M; Montanelli A; Favagrossa GM; Terzi A; Marcobruni N; Magoni M; Franchini D; Radaeli A; Tantucci C; Grassi V
Recenti Prog Med; 2000; 91(7-8):352-61. PubMed ID: 10932919
[TBL] [Abstract][Full Text] [Related]
33. Lung function in asthma: relation to clinics, challenge tests and immunotherapy.
Palma-Carlos AG; Palma-Carlos ML
Eur Ann Allergy Clin Immunol; 2003 Jun; 35(6):195-8. PubMed ID: 12872676
[TBL] [Abstract][Full Text] [Related]
34. Relationship between lung function and asthma symptoms in patients with difficult to control asthma.
Aburuz S; McElnay J; Gamble J; Millership J; Heaney L
J Asthma; 2005 Dec; 42(10):859-64. PubMed ID: 16393725
[TBL] [Abstract][Full Text] [Related]
35. Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection.
Brunelli A; Refai MA; Salati M; Sabbatini A; Morgan-Hughes NJ; Rocco G
Eur J Cardiothorac Surg; 2006 Apr; 29(4):567-70. PubMed ID: 16481190
[TBL] [Abstract][Full Text] [Related]
36. Antinuclear antibodies in asthma patients- a special asthma phenotype?
Agache I; Duca L; Anghel M; Pamfil G
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):49-52. PubMed ID: 19279359
[TBL] [Abstract][Full Text] [Related]
37. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages.
Chan ED; Kaminska AM; Gill W; Chmura K; Feldman NE; Bai X; Floyd CM; Fulton KE; Huitt GA; Strand MJ; Iseman MD; Shapiro L
Scand J Infect Dis; 2007; 39(8):690-6. PubMed ID: 17654345
[TBL] [Abstract][Full Text] [Related]
38. Mortality and airflow obstruction in asthma: a 17-year follow-up study.
Panizza JA; James AL; Ryan G; de Klerk N; Finucane KE
Intern Med J; 2006 Dec; 36(12):773-80. PubMed ID: 17096740
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical and genetic characterization of the M Cagliari alpha-1-antitrypsin molecule (M-like alpha-1-antitrypsin deficiency).
Sergi C; Consalez GG; Fabbretti G; Brisigotti M; Faa G; Costa V; Romeo G; Callea F
Lab Invest; 1994 Jan; 70(1):130-3. PubMed ID: 8302013
[TBL] [Abstract][Full Text] [Related]
40. [The rate of airflow limitation among the elderly undergoing spirometry in a university hospital].
Tojo N; Umino T; Miyasaka N
Rinsho Byori; 2004 Aug; 52(8):649-54. PubMed ID: 15478620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
